CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings (Deficit)	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Noncontrolling Interest
Beginning Balance at Dec. 31, 2023	$ 4,820,681	$ 5,166	$ 6,407,294	$ 57,035	$ 472	$ (1,657,675)	$ 8,389
Beginning Balance (in shares) at Dec. 31, 2023		516,775,000
Net income (loss)	51,706			51,235			471
Foreign currency translation adjustment	(993)				(993)	0
Vesting of restricted stock units	0	$ 14	(14)
Vesting of restricted stock units (in shares)		1,363,000
Stock-based compensation	12,051		12,051
Payment of cash dividends	(32,553)			(32,553)
Dividend equivalents	(422)			(422)
Purchase of treasury stock	(98,613)					(98,613)
Ending Balance at Mar. 31, 2024	4,751,857	$ 5,180	6,419,331	75,295	(521)	(1,756,288)	8,860
Ending Balance (in shares) at Mar. 31, 2024		518,138,000
Beginning Balance at Dec. 31, 2024	$ 3,475,844	$ 5,206	6,453,606	(1,039,338)	(2,584)	(1,951,067)	10,021
Beginning Balance (in shares) at Dec. 31, 2024	520,784,783	520,785,000
Net income (loss)	$ 1,290			1,005			285
Distributions to noncontrolling interest	(1,892)						(1,892)
Foreign currency translation adjustment	(289)				(289)
Vesting of restricted stock units	0	$ 10	(10)
Vesting of restricted stock units (in shares)		970,000
Stock-based compensation	12,289		12,289
Payment of cash dividends	(30,877)			(30,877)
Dividend equivalents	(665)			(665)
Purchase of treasury stock	(20,295)					(20,295)
Ending Balance at Mar. 31, 2025	$ 3,435,405	$ 5,216	$ 6,465,885	$ (1,069,875)	$ (2,873)	$ (1,971,362)	$ 8,414
Ending Balance (in shares) at Mar. 31, 2025	521,755,322	521,755,000